Ganbat, Mandukhai
Loading...
Товч нэр
Ganbat, Mandukhai
Бүтэн нэр
Ganbat Mandukhai
Латин нэр
Ganbat Mandukhai
Албан тушаал
Судлаач
ORCID
Scopus Author ID
4 results
Now showing 1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Socioeconomic Factors Related to Nicotine Dependence in Mongolia(Mongolian National University of Medical Sciences, 2023-03-22); ; Objectives: This study is aimed to investigate potential socio-economic risk factors associated with Nicotine Dependence among UB residents. It is important to identify and understand the various elements that may make people more susceptible to the negative health effects of smoking. Methods: We applied a cross-sectional study design to define the level of nicotine dependence on 875 participants. In addition, risk factors associated with nicotine dependence were assessed through a questionnaire survey. Results: Higher nicotine dependence in this study was associated with being a female (OR=1.208), older age groups (OR=1.5-2.9), divorced (OR=1.091), living in a house (OR=1.602), having a high school education level (OR=1.794), not having a regular job (OR=1.137), having a higher alcohol consumption level (OR=1.18-1.62), and age at initiation of smoking at 18 or younger (OR=1.796). Conclusion: According to the results of our research, countries with low and moderate levels of income, such as Mongolia, have a significant problem with high levels of nicotine dependence. In addition to this, it underscores the importance of developing smoking cessation programs that consider the extent of nicotine dependence while placing a greater emphasis on early interventions of the linked factors. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Evaluating Smoking Cessation Counseling Bundle Behavioral Intervention for Mongolian Adults Who Use Nicotine Patches(Mongolian National University of Medical Sciences, 2023-03-20); ; ; Objectives: The objective of this study is to evaluate the effectiveness of a behavioral intervention based on the World Health Organization (WHO) 5A and 5R guidelines in Mongolia who use the Nicotine Replacement Therapy (NRT) patch. The study aims to assess the impact of the intervention on smoking cessation rate. The finding of this study will contribute to the existing literature on smoking cessation interventions and provide valuable insights into the effectiveness of a behavioral approach in a Mongolian population. Methods: In the intervention study, out of total of 806 people interested in the part of this study. The study team excluded their eligibility criteria of the study participant. A sample of 625 people who fulfilled study inclusion criteria received advice about the negative consequences of tobacco. After that, 479 people decided to quit smoking and 41 people were excluded due to health contraindications, and the final sample 454 people began nicotine replacement therapy to quit smoking. Participants in the treatment group received nicotine replacement patches for 28 days, while those in the counseling group received four sessions of behavioral change counseling (5A, 5R). Results: 454 were found to be eligible to take part in the study and were subsequently assigned to one of two groups, with 230 and 224 participants assigned to each group, respectively. In the second month of follow-up, 90 (39.1%) of participants who received NRT patches quit smoking. The group that received NRT + Behavioral intervention was 1.02 times as successful, or 0.7% more effective, than the group that did not receive behavioral intervention (P=0.872). Conclusion: WHO 5A, 5R brief counselling were more effective than group without behavioral intervention for smoking cessation, but difference was insignificant. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Health-Seeking Behavior among Tuberculosis Suspected Cases in Major Cities of Mongolia(Mongolian National University of Medical Sciences, 2019-09-25); - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey(Elsevier BV, 2021-12); ; ; BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.Scopus© Citations 14